QNCX

$0.00

(

+0.00%

) Quote details
Add to Watchlist Run Backtest
stock

Quince Therapeutics, Inc.

NASDAQ | QNCX

1.95

USD

+$0.00

(

+0.00%

)

At Close (As of Oct 13, 2025)

$100.45M

Market Cap

-

P/E Ratio

-1.1

EPS

$2.45

52 Week High

$0.71

52 Week Low

HEALTHCARE

Sector

QNCX Chart

Recent Chart
Price Action

QNCX Technicals

Tags:

QNCX Earnings

Yearly Income Statement (As of Dec 31, 2024)

Field Value (USD)
Gross Profit -$186K
Total Revenue $0
Cost Of Revenue $186K
Costof Goods And Services Sold $186K
Operating Income -$57M
Selling General And Administrative $18M
Research And Development $19M
Operating Expenses $36M
Investment Income Net -
Net Interest Income $2.9M
Interest Income $2.9M
Interest Expense -
Non Interest Income -
Other Non Operating Income -
Depreciation -
Depreciation And Amortization $186K
Income Before Tax -$57M
Income Tax Expense $87K
Interest And Debt Expense -
Net Income From Continuing Operations -$57M
Comprehensive Income Net Of Tax -
Ebit -$57M
Ebitda -$57M
Net Income -$57M

Revenue & Profitability

Earnings Performance

QNCX Financials

yearly Balance Sheet (As of Dec 31, 2024)

Field Value (USD)
Total Assets $114M
Total Current Assets $44M
Cash And Cash Equivalents At Carrying Value $6.2M
Cash And Short Term Investments $6.2M
Inventory -
Current Net Receivables $882K
Total Non Current Assets $70M
Property Plant Equipment -
Accumulated Depreciation Amortization Ppe -
Intangible Assets $60M
Intangible Assets Excluding Goodwill $60M
Goodwill $0
Investments -
Long Term Investments $78K
Short Term Investments $35M
Other Current Assets $2.4M
Other Non Current Assets -
Total Liabilities $84M
Total Current Liabilities $7.3M
Current Accounts Payable $2.9M
Deferred Revenue -
Current Debt -
Short Term Debt $192K
Total Non Current Liabilities $77M
Capital Lease Obligations $490K
Long Term Debt $14M
Current Long Term Debt -
Long Term Debt Noncurrent -
Short Long Term Debt Total $15M
Other Current Liabilities $4.2M
Other Non Current Liabilities $57M
Total Shareholder Equity $30M
Treasury Stock -
Retained Earnings -$376M
Common Stock $44K
Common Stock Shares Outstanding $43M

yearly Cash Flow (As of Dec 31, 2024)

Field Value (USD)
Operating Cashflow -$32M
Payments For Operating Activities -
Proceeds From Operating Activities -
Change In Operating Liabilities -
Change In Operating Assets -
Depreciation Depletion And Amortization $186K
Capital Expenditures $257K
Change In Receivables -
Change In Inventory -
Profit Loss -
Cashflow From Investment $22M
Cashflow From Financing -$4.8M
Proceeds From Repayments Of Short Term Debt -
Payments For Repurchase Of Common Stock -
Payments For Repurchase Of Equity -
Payments For Repurchase Of Preferred Stock -
Dividend Payout -
Dividend Payout Common Stock -
Dividend Payout Preferred Stock -
Proceeds From Issuance Of Common Stock -
Proceeds From Issuance Of Long Term Debt And Capital Securities Net -
Proceeds From Issuance Of Preferred Stock -
Proceeds From Repurchase Of Equity -
Proceeds From Sale Of Treasury Stock -
Change In Cash And Cash Equivalents -
Change In Exchange Rate -
Net Income -$57M

yearly Income Statement (As of Dec 31, 2024)

Field Value (USD)
Gross Profit -$186K
Total Revenue $0
Cost Of Revenue $186K
Costof Goods And Services Sold $186K
Operating Income -$57M
Selling General And Administrative $18M
Research And Development $19M
Operating Expenses $36M
Investment Income Net -
Net Interest Income $2.9M
Interest Income $2.9M
Interest Expense -
Non Interest Income -
Other Non Operating Income -
Depreciation -
Depreciation And Amortization $186K
Income Before Tax -$57M
Income Tax Expense $87K
Interest And Debt Expense -
Net Income From Continuing Operations -$57M
Comprehensive Income Net Of Tax -
Ebit -$57M
Ebitda -$57M
Net Income -$57M

QNCX News

QNCX Profile

Quince Therapeutics, Inc. Profile

Sector: HEALTHCARE

Industry: BIOTECHNOLOGY

Quince Therapeutics, Inc. is a biopharmaceutical company headquartered in South San Francisco, California, dedicated to developing innovative precision therapies aimed at treating rare and debilitating diseases. Leveraging cutting-edge research and advanced therapeutic platforms, Quince is committed to transforming the treatment landscape for patients with unmet medical needs. The company's portfolio includes targeted treatments designed to improve patient outcomes and quality of life, positioning it as a leader in the biopharmaceutical sector. With a strong pipeline and a focus on scientific excellence, Quince Therapeutics is well-poised for growth and impactful contributions to healthcare.

VHAI
-25.00%
$0.00
YYAI
-12.21%
$0.16
STAI
+39.44%
$0.62
CGBS
-39.47%
$0.03
BURU
+6.25%
$0.50
ELBM
+334.95%
$7.17
PLUG
+13.44%
$3.87
GWH
+149.66%
$10.38
RGTI
+20.26%
$52.82
ASST
-35.33%
$1.00
BITF
+25.47%
$5.26
IONZ
-35.04%
$2.21
BYND
-47.01%
$1.06
NVDA
+2.25%
$187.29
NVTS
+23.51%
$10.16
DNN
+6.94%
$3.07
CAN
+33.93%
$1.45
QBTS
+23.97%
$40.93
INTC
+2.03%
$37.11
GPUS
-12.50%
$0.41
WULF
-0.58%
$13.51
JOBY
+2.61%
$16.70
AXDX
-61.36%
$0.03
BBD
+1.30%
$3.10
CLF
+4.66%
$13.79
TSLA
+5.01%
$434.23
F
+0.96%
$11.52
QS
+16.36%
$17.10
CRML
+56.07%
$23.38
NIO
+6.59%
$7.15
ETHD
-11.62%
$3.37
ACHR
+6.09%
$12.70
AMD
+0.40%
$215.76
PWM
+12.50%
$1.17
RXRX
+4.41%
$5.55
CIFR
+19.77%
$20.32
LAES
+13.49%
$6.14
APLD
+2.14%
$34.71
BTBT
+5.58%
$3.97
SOFI
+4.45%
$27.35
DVLT
-12.36%
$1.66
TLRY
+0.58%
$1.73
USAR
+17.01%
$38.15
DFLI
+41.35%
$1.54
ONDS
+18.43%
$10.92
RR
+7.85%
$6.38
SOUN
+10.77%
$19.23
WBD
-3.22%
$17.10
MP
+23.30%
$96.60
ABAT
+33.25%
$8.99
NAK
+26.47%
$2.56
RMBL
+60.50%
$3.21
IREN
+8.04%
$64.58
ADD
-25.47%
$0.05
CORZ
+2.66%
$18.52
UUUU
+18.40%
$24.08
AAL
+1.51%
$11.69
RIG
+3.24%
$3.18
MARA
+9.43%
$20.40
EPWK
-11.00%
$0.08
NAKA
-4.05%
$0.83
UAMY
+37.67%
$16.80
PLTR
+0.84%
$176.92
SRM
+53.27%
$10.30
NOK
-1.79%
$5.22
IONQ
+18.72%
$83.88
PFE
+0.10%
$24.80
ADAP
-0.70%
$0.18
BMNR
+7.40%
$56.35
QUBT
+10.49%
$21.01
GDXD
-12.99%
$0.74
SNAP
+3.14%
$8.02
XCH
+119.76%
$1.81
CJET
-14.93%
$0.12
MRVL
-5.52%
$85.61
QSI
+26.28%
$2.10
BULL
+1.62%
$11.58
NB
+3.81%
$10.78
CLSK
+2.49%
$19.76
MULN
-55.00%
$0.63
BINI
-55.00%
$0.63
CUTR
-10.19%
$0.09
PET
-59.91%
$0.04
AMZN
+1.81%
$220.30
AVGO
-5.90%
$324.63
NEHC
-8.12%
$2.60
WLGS
-5.57%
$0.04
BTG
+3.87%
$5.27
KDLY
-7.21%
$0.87
AMC
+0.68%
$2.95
ETWO
0.00%
$3.30
RF
+1.84%
$24.60
HOOD
+1.03%
$140.40
HPE
+2.76%
$25.07
PMAX
+75.28%
$4.54
TMC
+18.40%
$10.52
ABEV
+1.42%
$2.14
KDP
+3.02%
$26.60
RGTZ
-42.68%
$10.66
T
-1.10%
$25.58
VHAI
-25.00%
$0.00
YYAI
-12.21%
$0.16
STAI
+39.44%
$0.62
CGBS
-39.47%
$0.03
BURU
+6.25%
$0.50
ELBM
+334.95%
$7.17
PLUG
+13.44%
$3.87
GWH
+149.66%
$10.38
RGTI
+20.26%
$52.82
ASST
-35.33%
$1.00
BITF
+25.47%
$5.26
IONZ
-35.04%
$2.21
BYND
-47.01%
$1.06
NVDA
+2.25%
$187.29
NVTS
+23.51%
$10.16
DNN
+6.94%
$3.07
CAN
+33.93%
$1.45
QBTS
+23.97%
$40.93
INTC
+2.03%
$37.11
GPUS
-12.50%
$0.41
WULF
-0.58%
$13.51
JOBY
+2.61%
$16.70
AXDX
-61.36%
$0.03
BBD
+1.30%
$3.10
CLF
+4.66%
$13.79
TSLA
+5.01%
$434.23
F
+0.96%
$11.52
QS
+16.36%
$17.10
CRML
+56.07%
$23.38
NIO
+6.59%
$7.15
ETHD
-11.62%
$3.37
ACHR
+6.09%
$12.70
AMD
+0.40%
$215.76
PWM
+12.50%
$1.17
RXRX
+4.41%
$5.55
CIFR
+19.77%
$20.32
LAES
+13.49%
$6.14
APLD
+2.14%
$34.71
BTBT
+5.58%
$3.97
SOFI
+4.45%
$27.35
DVLT
-12.36%
$1.66
TLRY
+0.58%
$1.73
USAR
+17.01%
$38.15
DFLI
+41.35%
$1.54
ONDS
+18.43%
$10.92
RR
+7.85%
$6.38
SOUN
+10.77%
$19.23
WBD
-3.22%
$17.10
MP
+23.30%
$96.60
ABAT
+33.25%
$8.99
NAK
+26.47%
$2.56
RMBL
+60.50%
$3.21
IREN
+8.04%
$64.58
ADD
-25.47%
$0.05
CORZ
+2.66%
$18.52
UUUU
+18.40%
$24.08
AAL
+1.51%
$11.69
RIG
+3.24%
$3.18
MARA
+9.43%
$20.40
EPWK
-11.00%
$0.08
NAKA
-4.05%
$0.83
UAMY
+37.67%
$16.80
PLTR
+0.84%
$176.92
SRM
+53.27%
$10.30
NOK
-1.79%
$5.22
IONQ
+18.72%
$83.88
PFE
+0.10%
$24.80
ADAP
-0.70%
$0.18
BMNR
+7.40%
$56.35
QUBT
+10.49%
$21.01
GDXD
-12.99%
$0.74
SNAP
+3.14%
$8.02
XCH
+119.76%
$1.81
CJET
-14.93%
$0.12
MRVL
-5.52%
$85.61
QSI
+26.28%
$2.10
BULL
+1.62%
$11.58
NB
+3.81%
$10.78
CLSK
+2.49%
$19.76
MULN
-55.00%
$0.63
BINI
-55.00%
$0.63
CUTR
-10.19%
$0.09
PET
-59.91%
$0.04
AMZN
+1.81%
$220.30
AVGO
-5.90%
$324.63
NEHC
-8.12%
$2.60
WLGS
-5.57%
$0.04
BTG
+3.87%
$5.27
KDLY
-7.21%
$0.87
AMC
+0.68%
$2.95
ETWO
0.00%
$3.30
RF
+1.84%
$24.60
HOOD
+1.03%
$140.40
HPE
+2.76%
$25.07
PMAX
+75.28%
$4.54
TMC
+18.40%
$10.52
ABEV
+1.42%
$2.14
KDP
+3.02%
$26.60
RGTZ
-42.68%
$10.66
T
-1.10%
$25.58
2025 © AfterPullback LTD

Charts powered by TradingView

Market data may be delayed by 15 minutes or more and is provided by financial exchanges or third-party providers. AfterPullback does not verify or guarantee its accuracy and assumes no responsibility to do so. This website is not operated by a licensed attorney, accountant, or financial advisor. Nothing on this site constitutes financial advice or replaces consultation with a qualified professional who understands your specific circumstances. Always consult a licensed financial advisor before making investment decisions.